Results 121 to 130 of about 7,167 (179)

Parkinson's-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa. [PDF]

Mov Disord
Mark JR, Staley HA, Titus AM, Agin-Liebes J, Garrido A, Hughes L, Dzamko N, Wallings RL, Tansey MG.   +8 more
europepmc   +1 more source

Sphingolipids in Gaucher disease: a systematic review. [PDF]

Orphanet J Rare Dis
Lake A, Fuller M.
europepmc   +1 more source

Genetic susceptibility and environmental factors in dementia with Lewy bodies: Converging pathogenic mechanisms. [PDF]

Front Neurol
Berrios W, Golimstok A, Fernández MC.
europepmc   +1 more source

Safety and Efficacy of Ambroxol Therapy in Polish Patients with Gaucher Disease. [PDF]

Life (Basel)
Lipiński P, Rokicki D, Chwiałkowska K, Ciborowski M, Godzień J, Jezela-Stanek A, Korotko U, Kwaśniewski M, Niemira M, Szymańska-Rożek P, Syczewska M, Tylki-Szymańska A.   +11 more
europepmc   +1 more source

Development of a Lentiviral Vector for High-Yield Production of Synthetic and Recombinant GCase for Gaucher Disease Therapy. [PDF]

Int J Mol Sci
Coelho AC, Wiezel CEV, de Campos AC, Figueiredo LLS, Suardi GAM, de Paula Bernardes J, da Cunha Tirapelli DP, Faça VM, Abraham KJ, Carlotti-Júnior CG, Siciliano V, Weiss R, Gerson S, Fontes AM.   +13 more
europepmc   +1 more source

Population Pharmacokinetic/Pharmacodynamic Modeling of Therapeutic Enzymes in Lysosomal Storage Diseases. [PDF]

Clin Pharmacokinet
Barzel I, van der Ploeg AT, Pijnappel WWMP, van der Kuy PHM, van den Hout JMP, Preijers T.   +5 more
europepmc   +1 more source

Case Report: Clinical case analysis of gaucher disease management in a resource-limited setting: a single center experience from Kashigar, Xinjiang Uygur Autonomous Region, the Western China. [PDF]

Front Pediatr
Maimaititusvn G, Kulaixi M, Atawula A, Liu F.   +3 more
europepmc   +1 more source

Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson's disease. [PDF]

Transl Neurodegener
Sheshadri P, Costa-Besada MA, Fisher A, Kiraly S, Singh K, Kourouzidou I, Blacker TS, Zeng J, Shirihai OS, Grinstaff MW, Duchen MR.   +10 more
europepmc   +1 more source

APOE, Aβ42, and tau differentially impact cognitive decline in Sporadic, GBA1 and LRRK2 Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Botta R, Locascio JJ, Ye R, Goodheart AE, Gomperts SN.   +4 more
europepmc   +1 more source

Cytotoxic lymphocyte effector function is unaffected in patients with Gaucher disease. [PDF]

Front Immunol
Zou J, Noori T, Walterfang M, Szer J, Trapani JA, Voskoboinik I.   +5 more
europepmc   +1 more source